Synedgen's Debt - II Round

Synedgen raised a round of funding on September 12, 2017.

Synedgen is a bio-pharmaceutical company committed to developing therapies and products that reduce infection and inflammation at dermal, oral, mucosal and ophthalmic surfaces. Synedgen is using polys…

Articles about Synedgen's Debt - II Round: